Uniphar (LON:UPR) Reaches New 1-Year High - Here's What Happened

Uniphar plc (LON:UPR - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 240 ($3.19) and last traded at GBX 237 ($3.15), with a volume of 39509 shares trading hands. The stock had previously closed at GBX 235 ($3.13).

Analyst Upgrades and Downgrades

Separately, Shore Capital reaffirmed a "buy" rating on shares of Uniphar in a research note on Tuesday, February 25th.

Uniphar Stock Performance

The business's fifty day moving average price is GBX 223.78 and its two-hundred day moving average price is GBX 198.32. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The stock has a market capitalization of £771.98 million, a P/E ratio of 17.24 and a beta of 0.75.

Uniphar Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, May 16th. Stockholders of record on Thursday, April 24th will be paid a €0.01 ($0.01) dividend. This represents a dividend yield of 0.47%. This is a positive change from Uniphar's previous dividend of $0.01. The ex-dividend date of this dividend is Thursday, April 24th. Uniphar's dividend payout ratio (DPR) is presently 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.